Vol 19, No 3 (2014)
Published online: 2014-05-01

open access

Page views 147
Article views/downloads 209
Get Citation

Connect on Social Media

Connect on Social Media

Radiation therapy in the last month of life

Anand Patel1, Jacquelyn Dunmore-Griffith1, Stephen Lutz2, Peter A.S. Johnstone3
DOI: 10.1016/j.rpor.2013.09.010
Rep Pract Oncol Radiother 2014;19(3):191-194.

Abstract

Aim

We sought to survey a large, multi-center patient sample to better characterize/quantify RT utilization at the end of life.

Background

Few objective data exist for radiation therapy (RT) delivery at end of life (EOL).

Materials and methods

Data were retrieved for all patients receiving RT in calendar year 2010 in the Department of Radiation Oncology at Indiana University (IU) and Howard University (HU) hospitals. Specific attention was made of the group of patients receiving RT in the last 30 days of life.

Results

A total of 852 patients received all or part of their RT during 2010 (HU: 139, IU: 713). At time of analysis in early 2012, 179 patients had died (21%). Fifty-four patients (6.3% of total; 30% of expired patients) died within 30 days of receiving their last treatment. Twenty patients (2.3% of total; 11.2% of expired patients) received RT within their last week of life. For both sites, the median time until death from completion of therapy was 12.5 days (range 2–30 days).

Conclusions

Radiation in the last month of life is likely to provide minimal palliation or survival benefit. This, coupled with the financial implications, time investment, and physical costs, suggests that physicians and patients should more strongly consider hospice, and minimize duration of palliative RT courses as far as possible. As with chemotherapy, RT utilization at EOL should be considered for collection as an overuse metric.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy